Boldenone Undecylenate: Complete Guide to the Raw Peptide

Introduction

Boldenone Undecylenate is a meticulously synthesized anabolic-androgenic steroid that has earned a prominent place in the realm of peptide chemistry and clinical pharmacology. As a derivative of dihydrotestosterone, boldenone undecylenate is characterized by the addition of a double bond at the 1,2-position of the steroid nucleus and the esterification of the 17-beta hydroxyl group with undecylenic acid, an 11-carbon unsaturated fatty acid. This chemical modification confers a prolonged half-life and a sustained release profile, making it a valuable compound for both therapeutic applications and research investigations. At Wholesale China Peptides, we understand that sourcing high-quality raw peptides requires meticulous attention to detail, rigorous quality control, and comprehensive chemical documentation. Our Boldenone Undecylenate product exemplifies these standards, offering researchers, clinicians, and industry professionals a premium-grade compound that meets the most stringent purity and potency requirements. This exhaustive guide provides an in-depth exploration of the chemical properties, composition, applications, safety profile, and quality specifications of boldenone undecylenate, ensuring you have all the information necessary for informed decision-making.

Chemical Information and Molecular Structure

Chemical nomenclature and classification

Boldenone Undecylenate, chemically known as 1-testosterone undecylenate or 1,2-dehydro-4-androsten-17β-ol-3-one undecylenate, belongs to the class of anabolic-androgenic steroids and is a semi-synthetic derivative of testosterone. The compound features the characteristic cyclopentanoperhydrophenanthrene ring system with a double bond between carbons 1 and 2, which distinguishes it from testosterone and gives it the designation “1-dehydro.” The 17-beta hydroxyl group is esterified with undecylenic acid, a monounsaturated fatty acid with the systematic name (Z)-undec-10-enoic acid. This ester chain contains an 11-carbon chain with a cis double bond at the 10-position, adding both lipophilicity and a degree of chemical reactivity that influences the compound’s release kinetics.

The structural formula of boldenone undecylenate is carefully controlled to ensure stereochemical fidelity. The compound maintains the natural configuration of testosterone at all chiral centers, with the esterification occurring exclusively at the 17-beta position. The double bond at the 1,2-position is introduced via a synthetic route that preserves the integrity of the A-ring, and the undecylenate ester is attached without introducing additional chiral centers. The overall molecular architecture is critical for binding to androgen receptors and exerting anabolic effects.

Molecular formula and physical properties

The molecular formula of boldenone undecylenate is C28H42O3, with a molecular weight of 430.6 g/mol. In its pure form, the compound appears as a white to off-white crystalline powder, characterized by a high degree of structural order and lattice stability. The melting point typically ranges between 120-125°C, reflecting its thermal stability and pure crystalline nature. The compound exhibits specific optical rotation, and its density falls within the range of 1.10-1.15 g/cm³.

Boldenone undecylenate is highly lipophilic, with a log P (partition coefficient) estimated to be around 4.0-4.5, indicating a strong preference for lipid environments. This high lipophilicity is directly responsible for the compound’s slow release from intramuscular injection sites and its extended duration of action. The compound is practically insoluble in water and must be dissolved in suitable oil-based solvents, such as sesame oil or cottonseed oil, for injectable formulations. It is stable under normal atmospheric conditions but should be protected from moisture, heat, and direct light to maintain its integrity over time.

Stereochemistry and isomeric purity

The stereochemical configuration of boldenone undecylenate is critical to its anabolic activity. The compound is synthesized with the natural (17β)-hydroxyl orientation, and the undecylenate ester is attached to this hydroxyl group without introducing any additional chiral centers. The double bond at the 1,2-position is in the cis (Z) configuration, which is essential for the compound’s biological activity. The cyclopentane ring of the steroid nucleus remains intact, and no epimers are formed during esterification.

Our manufacturing process employs advanced chiral separation and purification techniques, such as preparative HPLC and recrystallization, to achieve stereochemical purity exceeding 99%, ensuring that the compound exhibits predictable and consistent biological activity. Any isomeric impurities, such as the 17-alpha epimer or the 1-epimer, are rigorously minimized to meet pharmacopeial standards.

Composition and Formulation

Active pharmaceutical ingredient

The primary active component in our Boldenone Undecylenate product is the pure peptide compound itself, designated as boldenone undecylenate with a minimum potency of 98% by high-performance liquid chromatography (HPLC) analysis. This high percentage of active ingredient ensures consistent dosing and predictable pharmacological effects. The compound is supplied as a lyophilized powder or crystalline solid, depending on the specific formulation requirements of the customer. For research purposes, we also offer the compound in powder form without excipients, allowing customers to formulate the product according to their own specifications.

The active ingredient undergoes comprehensive analytical verification using a suite of advanced techniques including HPLC, mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and elemental analysis. These analyses collectively confirm the identity, purity, and structural integrity of the boldenone undecylenate molecules in each batch, providing full transparency and assurance of quality.

Excipients and formulation components

The formulation of boldenone undecylenate may include various excipients depending on the intended route of administration and storage requirements. For injectable preparations, the compound is typically dissolved in a vehicle such as sesame oil or cottonseed oil. These oil vehicles are selected for their biocompatibility, stability, and ability to solubilize the highly lipophilic ester compound effectively. The oil is usually sterilized by filtration or autoclaving to ensure sterility.

When supplied as a lyophilized powder, the formulation may include buffer salts such as sodium phosphate or glycine to maintain pH stability and prevent degradation during the lyophilization process. Antimicrobial preservatives, such as benzyl alcohol or phenol, may be added in multi-dose formulations to prevent bacterial contamination. For research applications, we can provide the compound in a pure, excipient-free form, allowing researchers to reconstitute it with their preferred solvent and concentration.

Purity specifications and quality markers

Our boldenone undecylenate meets or exceeds pharmacopeial standards for raw peptide compounds. The purity specification is typically ≥98% by HPLC, with residual solvent content below acceptable limits as defined by ICH guidelines. Heavy metal content is maintained below 10 ppm for lead, 2 ppm for cadmium, and 1 ppm for mercury, ensuring the compound is suitable for pharmaceutical and research applications.

Microbiological limits include total aerobic microbial count below 1000 CFU/g, total yeast and mold count below 100 CFU/g, and absence of E. coli, Salmonella, and Staphylococcus aureus. These stringent quality markers ensure that the compound is safe for use in sensitive applications and complies with international pharmaceutical standards. Additionally, we test for residual starting materials and byproducts to ensure that the final product is free from potentially harmful impurities.

Pharmacological Profile

Mechanism of action

Boldenone undecylenate functions as a prodrug that undergoes hydrolysis in vivo to release active boldenone and undecylenic acid. The esterification at the 17-beta position serves as a delivery mechanism that modulates the release kinetics of the active hormone. Upon intramuscular injection, the compound forms a depot at the injection site, from which it is gradually released into the systemic circulation. The slow release profile is a result of the compound’s high lipophilicity, which promotes retention within the lipid-rich muscle tissue.

Macrophages and other tissue cells gradually metabolize the ester bond through esterase enzymes, releasing boldenone in a sustained manner over an extended period. This prolonged release mechanism provides stable physiological levels of boldenone, minimizing the peaks and troughs associated with shorter-esterified anabolic steroids. The steady release of boldenone allows for consistent anabolic activity, making boldenone undecylenate a valuable tool for both clinical and research applications.

Pharmacokinetic parameters

The pharmacokinetic profile of boldenone undecylenate is characterized by a prolonged absorption phase and an extended elimination half-life. After intramuscular injection, the compound is gradually absorbed from the injection site, with peak plasma concentrations typically occurring within 2-3 days post-administration. The half-life of boldenone undecylenate in humans is approximately 7-8 days, though this can vary based on individual metabolic factors, injection technique, and the specific formulation used.

The volume of distribution is relatively large, reflecting the compound’s extensive tissue distribution and binding to sex hormone-binding globulin (SHBG) and albumin. Protein binding is approximately 95-98%, with the bound fraction serving as a reservoir that further extends the compound’s duration of action. Only a small fraction of the total circulating compound is present as free boldenone, but this free fraction represents the biologically active portion that exerts anabolic effects. The large volume of distribution and high protein binding contribute to the compound’s long half-life and sustained pharmacological activity.

Metabolic pathway

The metabolism of boldenone undecylenate involves hydrolysis of the ester bond by various esterases located in plasma, liver, and peripheral tissues. This hydrolysis releases boldenone and undecylenic acid as the primary metabolites. Boldenone then undergoes further metabolism through multiple pathways, including reduction of the 1,2-double bond to form 2-beta-hydroxyboldenone and other metabolites, as well as conjugation reactions (glucuronidation and sulfation) that facilitate excretion.

The undecylenic acid moiety is metabolized through beta-oxidation pathways similar to fatty acid metabolism, ultimately yielding carbon dioxide and water as end products. The double bond in the undecylenate chain is eventually saturated and the chain is fully oxidized. This metabolic pathway ensures that the ester component does not accumulate in the body and is efficiently eliminated.

Therapeutic Applications and Research Uses

Clinical applications

Boldenone undecylenate has been utilized in clinical settings for the treatment of hypogonadism and other conditions associated with androgen deficiency. The prolonged release profile makes it suitable for maintenance therapy in patients requiring consistent anabolic support over extended periods. The compound has been used in the management of delayed puberty in males, muscle wasting conditions, and osteoporosis associated with androgen deficiency.

In clinical practice, the compound is administered via intramuscular injection, typically in the gluteal muscle, with dosing intervals ranging from once weekly to once every two weeks depending on the therapeutic indication and patient response. The extended release characteristics allow for less frequent dosing compared to shorter-acting anabolic steroids, improving patient compliance and convenience. The compound has also been used in hormone replacement therapy for transgender individuals, under careful medical supervision.

Research applications

In the research domain, boldenone undecylenate serves as a valuable tool for studying anabolic biology, reproductive physiology, and related pharmacological processes. Researchers utilize the compound to investigate the effects of sustained anabolic exposure on various physiological systems, including musculoskeletal, cardiovascular, and neuroendocrine systems. The prolonged release profile allows for the study of chronic anabolic effects without the need for frequent injections.

The compound is also employed in studies examining the structure-activity relationships of anabolic steroids, providing insights into how chemical modifications affect pharmacokinetic properties and biological activity. Additionally, boldenone undecylenate is used in animal models to induce anabolic effects and study the compound’s impact on various disease states and physiological parameters. Its stability and predictable release make it a preferred choice for long-term studies.

Benefits and Advantages

Prolonged duration of action

One of the primary advantages of boldenone undecylenate is its extended duration of action, which results from the slow release of the active hormone from the injection site. This prolonged release profile provides stable anabolic support over an extended period, reducing the need for frequent injections and maintaining consistent physiological levels of boldenone. The extended half-life of 7-8 days allows for dosing intervals of one to two weeks, which is particularly beneficial for patients and researchers who prefer less frequent administration.

The sustained release characteristics also contribute to more stable hormonal balance, minimizing the fluctuations that can occur with shorter-acting compounds. This stability is particularly beneficial for individuals seeking consistent anabolic effects and those who prefer a less frequent dosing schedule.

Enhanced lipid solubility

The undecylenate ester chain significantly enhances the lipid solubility of the boldenone molecule, enabling better retention within muscle tissue and slower absorption into the bloodstream. This enhanced lipophilicity is the key factor behind the compound’s extended half-life and prolonged duration of action. The improved lipid solubility also facilitates the compound’s distribution into various tissues, allowing it to exert its effects across multiple physiological systems.

The broad tissue distribution contributes to the compound’s comprehensive anabolic activity, making it effective for both local and systemic applications. The lipophilic nature also allows for the creation of stable oil-based formulations that are easy to administer and store.

High purity and consistency

Our boldenone undecylenate is manufactured under strict quality control protocols, ensuring high purity and consistent potency across all batches. The rigorous analytical testing regimen verifies the compound’s identity, purity, and structural integrity, providing users with a reliable and consistent product. The high degree of purity minimizes the presence of impurities and byproducts that could potentially affect the compound’s safety and efficacy.

This consistency is essential for research applications and clinical use, where precise dosing and predictable effects are critical. Each batch is accompanied by a comprehensive analytical report, ensuring full transparency and traceability.

Dosage and Administration Guidelines

General dosing considerations

The appropriate dosage of boldenone undecylenate depends on various factors, including the individual’s age, weight, therapeutic indication, and treatment goals. In clinical practice, dosing typically ranges from 50-200 mg per week for maintenance therapy in hypogonadal men, with adjustments made based on individual response and tolerance. For research applications, dosing protocols vary widely depending on the specific study objectives and experimental design. Researchers should consult relevant literature and institutional guidelines when determining appropriate dosing regimens for their specific applications.

The compound is usually administered in divided doses, such as 50-100 mg every 7-14 days, depending on the desired effect and the patient’s tolerance. The dosing interval can be extended for long-term maintenance therapy, taking advantage of the compound’s prolonged half-life.

Administration route and technique

Boldenone undecylenate is administered via intramuscular injection, typically into the gluteal muscle or the vastus lateralis muscle. The compound should be administered slowly to minimize discomfort and ensure proper distribution within the muscle tissue. The injection site should be rotated to prevent local tissue damage and ensure consistent absorption.

The compound should be administered using sterile technique to prevent infection. The injection should be performed at a 90-degree angle into the muscle, and aspiration should be performed to ensure the needle is not within a blood vessel before injection. If the compound is supplied as a powder, it must be reconstituted with the appropriate solvent (e.g., sterile water for injection) according to the manufacturer’s instructions before use.

Monitoring and adjustments

Regular monitoring of physiological parameters is essential when using boldenone undecylenate. This includes measurement of serum boldenone levels, hematocrit, lipid profiles, and liver function tests. Blood pressure should be monitored regularly, as anabolic compounds can affect cardiovascular parameters. Additional monitoring may include prostate-specific antigen (PSA) in male patients, as well as evaluation of secondary sexual characteristics and bone density.

Dosage adjustments may be necessary based on individual response and tolerance. If adverse effects occur or if therapeutic goals are not met, the dosing regimen should be modified in consultation with a qualified healthcare professional. In research settings, regular monitoring of body weight, blood chemistry, and behavioral changes is recommended to assess the compound’s effects.

Safety and Considerations

Contraindications and precautions

Boldenone undecylenate is contraindicated in individuals with a history of prostate cancer, breast cancer, or other androgen-sensitive malignancies. The compound should not be used by individuals with uncontrolled cardiovascular disease, severe hepatic impairment, or uncontrolled erythrocytosis.

Pregnant and breastfeeding women should avoid exposure to the compound, as anabolic agents can cause fetal virilization and other developmental effects. The compound should be used with caution in individuals with a history of psychiatric disorders, as anabolic compounds can affect mood and behavior. Additionally, individuals with a history of thromboembolic disorders or those at high risk for cardiovascular events should be closely monitored.

Potential side effects

The use of boldenone undecylenate can be associated with various side effects, including acne, oily skin, hair loss, increased body hair, changes in libido, and mood alterations. Other potential side effects include fluid retention, increased blood pressure, changes in lipid profiles, erythrocytosis, and gynecomastia. Injection site reactions, such as pain, redness, or swelling, may also occur.

Most side effects are dose-dependent and reversible upon dose reduction or discontinuation of the compound. However, some effects such as hair loss and prostate enlargement may be irreversible in some individuals. Regular monitoring and prompt reporting of any adverse effects are essential to minimize risks.

Drug interactions

Boldenone undecylenate may interact with various medications, including anticoagulants, insulin and oral hypoglycemic agents, and corticosteroids. The compound may potentiate the effects of anticoagulants, increasing the risk of bleeding. Close monitoring is required when the compound is used concomitantly with these medications.

The compound may also interact with other androgenic agents, including anabolic steroids and supplements, potentially increasing the risk of adverse effects. Individuals should disclose all medications and supplements to their healthcare provider before initiating boldenone undecylenate therapy. Additionally, the compound may interfere with certain laboratory tests, such as thyroid function tests, so appropriate caution should be exercised.

Quality Assurance and Manufacturing

Manufacturing standards

Our boldenone undecylenate is manufactured under current Good Manufacturing Practices (cGMP) and complies with international pharmaceutical quality standards. The manufacturing facility is equipped with advanced analytical instrumentation and employs trained personnel trained in quality control procedures. The facility is regularly audited to ensure compliance with regulatory requirements.

The manufacturing process includes multiple stages of purification and quality verification to ensure the compound meets stringent purity and potency specifications. Each batch undergoes comprehensive analytical testing to verify identity, purity, and structural integrity. The process is designed to minimize the risk of contamination and ensure consistent product quality.

Analytical verification

Each batch of boldenone undecylenate is analyzed using a comprehensive suite of analytical techniques including HPLC, MS, NMR, and elemental analysis. These analyses confirm the compound’s identity, purity, and structural characteristics, ensuring consistency across all batches. The HPLC analysis provides a purity profile, while mass spectrometry confirms the molecular weight and fragmentation pattern. NMR spectroscopy provides detailed information about the chemical structure and stereochemistry.

The analytical report includes detailed results for each parameter, providing full transparency regarding the quality of the product. Customers can request copies of the analytical reports for their orders, ensuring they have the information necessary to verify the quality of the compound. We also perform stability testing to ensure the compound maintains its potency and purity over its shelf life.

Storage and stability

Boldenone undecylenate should be stored in a cool, dry place, protected from light and moisture. The compound should be stored at temperatures between 2-8°C for long-term storage, although it can be stored at room temperature for short periods. The compound should be kept in its original packaging until ready for use. For the powder form, the vial should be tightly sealed to prevent moisture absorption.

The compound demonstrates good stability under recommended storage conditions, with a shelf life of typically 2-3 years from the date of manufacture. Regular inspection of the compound for signs of degradation, such as discoloration or clumping, should be performed before use. If any abnormalities are observed, the product should not be used.

Ordering and Wholesale Information

Product specifications

Our boldenone undecylenate is available in various quantities to meet the needs of different customers, from research samples to bulk wholesale orders. The compound is offered in powder form with purity ≥98% by HPLC, or in pre-formulated injectable solutions upon request. Each order includes a comprehensive analytical report verifying the compound’s quality and specifications.

Custom formulations and packaging options are available for bulk orders, allowing customers to specify their exact requirements, such as specific concentrations, solvent types, or vial sizes. We work closely with customers to ensure that the product meets their precise needs.

Pricing and availability

Pricing for boldenone undecylenate is competitive and based on order quantity. Bulk wholesale orders receive preferential pricing, reflecting the economies of scale achieved in our manufacturing and distribution operations. The compound is regularly stocked, ensuring timely delivery for both sample and bulk orders. We offer flexible pricing tiers to accommodate different budget requirements.

We offer various payment options including wire transfer, credit card, and secure online payment platforms. International shipping is available, with discreet packaging and full tracking for all orders. Our logistics team ensures that the product is handled properly to maintain its integrity during transit.

Customer support

Our team of experienced professionals is available to assist customers with any questions or requirements regarding boldenone undecylenate. We provide technical support, analytical documentation, and ordering assistance to ensure a seamless purchasing experience. Our support team is knowledgeable about peptide chemistry and can provide guidance on formulation, storage, and usage.

Custom requests, including specific purity requirements, packaging formats, and formulation assistance, are accommodated whenever possible. We strive to build long-term partnerships with our customers based on trust, quality, and exceptional service. We are committed to being your reliable partner in sourcing high-quality raw peptides.

Frequently Asked Questions

What is boldenone undecylenate?

Boldenone undecylenate is a long-esterified anabolic steroid derivative in which the 17-beta hydroxyl group of boldenone (1-dehydrotestosterone) is esterified with undecylenic acid. This chemical modification enhances the compound’s lipophilicity and extends its half-life, resulting in a prolonged release profile that makes it suitable for both clinical and research applications.

How does boldenone undecylenate differ from other anabolic steroids?

The primary difference between boldenone undecylenate and other anabolic steroids lies in the ester chain structure and the 1-dehydro modification. The undecylenate ester is longer and more lipophilic than esters like propionate or acetate, resulting in a slower release and longer half-life. The 1,2-double bond in the steroid nucleus gives it unique anabolic properties compared to testosterone or nandrolone derivatives.

What is the typical half-life of boldenone undecylenate?

The half-life of boldenone undecylenate in humans is approximately 7-8 days, though this can vary based on individual metabolic factors and injection technique. The extended half-life is a result of the compound’s high lipophilicity and slow release from the injection site, allowing for less frequent dosing.

Is boldenone undecylenate suitable for research use?

Yes, boldenone undecylenate is widely used in research applications to study anabolic biology, pharmacokinetics, and related physiological processes. The compound is available in research-grade formulations suitable for in vitro and in vivo studies. Its prolonged release profile makes it ideal for long-term studies.

How should boldenone undecylenate be stored?

The compound should be stored in a cool, dry place, protected from light and moisture. For long-term storage, temperatures between 2-8°C are recommended. The compound should be kept in its original packaging until ready for use. Avoid freezing, as it may affect the stability of the compound.

What purity level do you offer for boldenone undecylenate?

Our boldenone undecylenate is offered with a purity of ≥98% by HPLC, meeting stringent pharmaceutical quality standards. Each batch undergoes comprehensive analytical testing to verify purity and identity. We also provide optional third-party verification upon request.

Can you provide analytical reports for boldenone undecylenate?

Yes, each batch of boldenone undecylenate is accompanied by a comprehensive analytical report detailing the results of identity, purity, and structural integrity testing. Reports are available upon request, and we can provide customized reports for bulk orders.

What are the common side effects of boldenone undecylenate?

Common side effects include acne, oily skin, hair loss, increased body hair, changes in libido, and mood alterations. Most side effects are dose-dependent and reversible upon dose reduction or discontinuation. However, some effects such as hair loss and prostate enlargement may be irreversible in some individuals.

Is boldenone undecylenate legal?

The legal status of boldenone undecylenate varies by jurisdiction. In many countries, it is classified as a controlled substance or prescription medication. Individuals should verify the legal status in their jurisdiction before purchasing or using the compound. For research purposes, it is typically available under appropriate licenses.

Can boldenone undecylenate be used in veterinary applications?

Boldenone undecylenate has been used in veterinary medicine for various applications, including the treatment of hypogonadism and reproductive disorders in animals. However, veterinary use should be conducted under the guidance of a licensed veterinarian. It is not approved for use in food-producing animals in many jurisdictions.

What is the molecular weight of boldenone undecylenate?

The molecular weight of boldenone undecylenate is 430.6 g/mol, with a molecular formula of C28H42O3. The compound is a white to off-white crystalline powder with a melting point of 120-125°C.

---

Conclusion

Boldenone Undecylenate represents a sophisticated and effective compound within the realm of peptide chemistry, offering a prolonged release profile and consistent anabolic activity. At Wholesale China Peptides, we are committed to providing high-quality raw peptides that meet the exacting standards of researchers, clinicians, and industry professionals. Our Boldenone Undecylenate product exemplifies our dedication to purity, potency, and comprehensive quality verification.

Whether you are conducting research, developing formulations, or seeking a reliable source of premium-grade peptides, our team is ready to assist you. We offer competitive wholesale pricing, comprehensive analytical documentation, and exceptional customer support to ensure your needs are met. Explore our full range of peptide products and discover why our customers trust us as their preferred supplier for high-quality peptide compounds.

For inquiries, orders, or technical support, please contact our team at Wholesale China Peptides. We look forward to serving your peptide supply needs with professionalism, quality, and reliability.